Price Transparency in the Management of Skull Base Tumors—The Price to Operate

Abstract

Background Due to the escalating health care costs in the United States, the Centers for Medicare and Medicaid Services (CMS) implemented a cost transparency initiative on January 1, 2021. Hospitals lack functional cost estimators or fail to provide pricing information for common skull base procedures.

Methods A list of the top 70 neurosurgery and otolaryngology hospital systems according to the US News and World Report rankings was made. Google searches for each hospital's cost estimator tool were conducted, recording its presence and accessibility time. Using the cost estimator tool, specific skull base procedure prices, Current Procedural Terminology codes, and contact information for personalized estimates were searched.

Results Fifty-seven hospitals (81%) were privately funded. The majority were urban teaching hospitals (n = 68; 97%). Geographical locations included 19 (27%) in the Northeast, 21 (30%) in the Midwest, 20 (29%) in the South, and 10 (14%) in the West. Of the 70 hospitals, 4 (5.7%) did not have a cost estimation website. Of the 66 hospitals that did, the average time to locate the cost of the skull-based procedures was 17.8 seconds (range 12–28 seconds). Only two (2.9%) hospitals had information for skull base procedures; both were radiosurgery procedures. The most common stereotactic radiosurgery offered was gamma knife radiosurgery (n = 50; 71%). A total of 19 hospitals (27%) did not include contact information for personalized cost estimation.

Conclusion The CMS price transparency guidelines are not designed to encompass skull base procedures. Due to this ambiguity, patients are unable to make informed financial decisions when selecting treatment options.

Keywords

skull base - cost - financial service - vestibular schwannoma - CMS

Publikationsverlauf

Eingereicht: 09. November 2023

Angenommen: 31. März 2024

Artikel online veröffentlicht:
01. Mai 2024

• References

• 1 Lu AJ, Chen EM, Vutam E, Brandt J, Sadda P. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate. Healthc (Amst) 2020; 8 (03) 100443
• 2 Majority of Americans stressed by health insurance costs. Accessed April 8, 2024 at: https://www.apa.org/monitor/2018/04/insurance-costs
• 3 Montero A. 2022. Americans' Challenges with Health Care Costs. KFF. Accessed April 8, 2024 at: https://www.kff.org/health-costs/issue-brief/americans-challenges-with-health-care-costs/
• 4 Mehrotra A, Chernew ME, Sinaiko AD. Promise and reality of price transparency. N Engl J Med 2018; 378 (14) 1348-1354
• 5 Medicare and Medicaid Programs. CY 2020 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates. Price Transparency Requirements for Hospitals To Make Standard Charges Public. Federal Register. Accessed April 8, 2024 at: https://www.federalregister.gov/documents/2019/11/27/2019-24931/medicare-and-medicaid-programs-cy-2020-hospital-outpatient-pps-policy-changes-and-payment-rates-and (2019)
• 6 Moon T, Bloom J, Youssef G. et al. Variable accessibility to consumer pricing among breast cancer operations. Ann Surg Oncol 2023; 30 (08) 4631-4635
• 7 Cale JB, Stambough JB, Mears SC, Hutchinson JD, Barnes CL, Stronach BM. Price transparency for primary hip & knee arthroplasty: an overview of the top 50 US news and world report orthopedic hospitals. J Arthroplasty 2022; 37 (08) 1514-1519
• 8 Wang AA, Xiao R, Sethi RKV, Rathi VK, Scangas GA. Private payer-negotiated prices for outpatient otolaryngologic surgery. Otolaryngol Head Neck Surg 2022; 167 (02) 262-265
• 9 Thai NLB, Mai NY, Vuong NL. et al. Treatment for vestibular schwannoma: systematic review and single arm meta-analysis. Am J Otolaryngol 2022; 43 (02) 103337
• 10 Healthcare Cost and Utilization Project (HCUP) NRD Notes. Accessed April 8, 2024 at: https://hcup-us.ahrq.gov/db/vars/hosp_bedsize/nrdnote.jsp
• 11 Sun GH. Price transparency in otolaryngology: more questions than answers. JAMA Otolaryngol Head Neck Surg 2020; 146 (04) 380-381
• 12 Fernández-Méndez R, Wan Y, Axon P, Joannides A. Incidence and presentation of vestibular schwannoma: a 3-year cohort registry study. Acta Neurochir (Wien) 2023; 165 (10) 2903-2911
• 13 Macielak RJ, Thao V, Borah BJ. et al. Lifetime cost and quality-adjusted life-years across management options for small- and medium-sized sporadic vestibular schwannoma. Otol Neurotol 2021; 42 (09) e1369-e1375
• 14 Schnurman Z, Golfinos JG, Epstein D, Friedmann DR, Roland JT, Kondziolka D. Comparing costs of microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg 2018; (e-pub ahead of print)